Comments on: Zanidatamab Yields Durable Responses in HER2+ Biliary Tract Cancer https://www.oncologynurseadvisor.com/home/cancer-types/gastrointestinal-cancer/zanidatamab-her2-biliary-tract-cancer-yields-durable-responses/ Fri, 13 Oct 2023 20:48:27 +0000 hourly 1 https://wordpress.org/?v=6.4.3